The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark

På svenska

Author

  • Marie Borggren
  • Sanne Skov Jensen
  • Leo Heyndrickx
  • Angelica A. Palm
  • Jan Gerstoft
  • Gitte Kronborg
  • Bo Langhoff Hønge
  • Sanne Jespersen
  • Zacarias José Da Silva
  • Ingrid Karlsson
  • Anders Fomsgaard
Show all

Summary, in English

The development of therapeutic and prophylactic HIV vaccines for African countries is urgently needed, but the question of what immunogens to use needs to be answered. One approach is to include HIV envelope immunogens derived from HIV-positive individuals from a geographically concentrated epidemic with more limited viral genetic diversity for a region-based vaccine. To address if there is a basis for a regional selected antibody vaccine, we have screened two regionally separate cohorts from Guinea-Bissau and Denmark for neutralizing antibody activity and antibody-dependent cellular cytotoxicity (ADCC) against local and nonlocal circulating HIV-1 strains. The neutralizing activity did not demonstrate higher potential against local circulating strains according to geography and subtype determination, but the plasma from Danish individuals demonstrated significantly higher inhibitory activity than that from Guinea-Bissau individuals against both local and nonlocal virus strains. Interestingly, an opposite pattern was observed with ADCC activity, where Guinea-Bissau individual plasma demonstrated higher activity than Danish plasma and was specifically against the local circulating subtype. Thus, on basis of samples from these two cohorts, no local-specific neutralizing activity was detected, but a local ADCC response was identified in the Guinea-Bissau samples, suggesting potential use of regional immunogens for an ADCC-inducing vaccine.

Publishing year

2016

Language

English

Pages

434-442

Publication/Series

AIDS Research and Human Retroviruses

Volume

32

Issue

5

Document type

Journal article

Publisher

Mary Ann Liebert, Inc.

Topic

  • Infectious Medicine

Status

Published

ISBN/ISSN/Other

  • ISSN: 0889-2229